Back to Journals » OncoTargets and Therapy » Volume 10

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Total article views   Abstract views HTML views PDF downloads Totals
11,231 Dovepress* 6,732 2,716+ 1,062 9,448
PubMed Central* 0 1,783 650 1,783
Totals 6,732 4,499 1,712 11,231
*Since 10 July 2017
+Since July 2016

View citations on PubMed Central and Google Scholar